23andMe trades drug dis­cov­ery for GLP-1 weight loss pre­scrip­tions

23andMe is shut­ting down its in­ter­nal drug dis­cov­ery group and get­ting in­to pre­scrip­tion weight loss drugs in an ef­fort to turn the strug­gling con­sumer ge­net­ic …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER